Autor: "Shimada K" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Hepatoid carcinoma and related entities of the extrahepatic bile duct: A clinicopathological study of four cases.
Autorzy:: Okura K; Department of Analytical Pathology, National Cancer Center Research Institute, Tokyo, Japan.
Esaki M; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Nara S; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Ban D; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Takamoto T; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Shimada K; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Hiraoka N; Department of Analytical Pathology, National Cancer Center Research Institute, Tokyo, Japan.; Pokaż więcej
Źródło:: Pathology international [Pathol Int] 2022 Jun; Vol. 72 (6), pp. 332-342. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*/pathology
Bile Duct Neoplasms*/pathology
Bile Ducts, Extrahepatic*/pathology
Cholangiocarcinoma*/pathology
Liver Neoplasms*/pathology
Aged ; Bile Ducts, Intrahepatic/pathology ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; alpha-Fetoproteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.
Autorzy:: Takano M; Departments of Diagnostic Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. .
Shimada K; Department of Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Fujii T; Department of Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Morita K; Departments of Diagnostic Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Takeda M; Departments of Diagnostic Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Nakajima Y; Department of Surgery, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Nonomura A; Hokuriku CPL, 15-36 Ninomiya-cho, Kanazawa, Ishikawa, 920-0067, Japan.
Konishi N; Department of Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Obayashi C; Departments of Diagnostic Pathology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2016 Nov 18; Vol. 16 (1), pp. 903. Date of Electronic Publication: 2016 Nov 18.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular/*genetics
Keratin-19/*genetics
Liver Neoplasms/*genetics
Neovascularization, Pathologic/*genetics
Adult ; Aged ; Aged, 80 and over ; Apoptosis/genetics ; Cadherins/genetics ; Cadherins/metabolism ; Carcinoma, Hepatocellular/blood supply ; Carcinoma, Hepatocellular/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Survival/genetics ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; Cyclin-Dependent Kinase Inhibitor p16/metabolism ; Cyclin-Dependent Kinase Inhibitor p27/genetics ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Liver Neoplasms/blood supply ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neovascularization, Pathologic/metabolism ; Prognosis ; RNA Interference

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: An extremely rare clinical manifestation of gallbladder cancer presenting with abdominal wall invasion with an erythematous skin break.
Autorzy:: Monma SE; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Shimada K; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Kishi Y; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Nara S; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Esaki M; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Fujiki M; Plastic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Miyamoto S; Plastic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Hiraoka N; Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.; Pokaż więcej
Źródło:: Pathology international [Pathol Int] 2016 May; Vol. 66 (5), pp. 302-4. Date of Electronic Publication: 2016 Jan 11.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Abdominal Pain/*pathology
Abdominal Wall/*pathology
Adenocarcinoma/*secondary
Gallbladder Neoplasms/*pathology
Liver Neoplasms/*secondary
Skin Neoplasms/*secondary
Abdominal Pain/diagnostic imaging ; Abdominal Pain/etiology ; Abdominal Wall/diagnostic imaging ; Adenocarcinoma/complications ; Adenocarcinoma/diagnostic imaging ; Aged ; Female ; Gallbladder Neoplasms/complications ; Gallbladder Neoplasms/diagnostic imaging ; Humans ; Liver Neoplasms/diagnostic imaging ; Skin Neoplasms/diagnostic imaging ; Tomography, X-Ray Computed

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Autorzy:: Totoki Y; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Tatsuno K; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Covington KR; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Ueda H; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Creighton CJ; 1] Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA. [2] Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Kato M; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Tsuji S; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Donehower LA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Slagle BL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Nakamura H; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Yamamoto S; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shinbrot E; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Hama N; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Lehmkuhl M; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Hosoda F; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Arai Y; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Walker K; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Dahdouli M; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Gotoh K; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Nagae G; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Gingras MC; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Muzny DM; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Ojima H; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.
Shimada K; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Midorikawa Y; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Goss JA; Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Cotton R; Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Hayashi A; 1] Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. [2] Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shibahara J; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ishikawa S; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Guiteau J; Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Tanaka M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Urushidate T; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Ohashi S; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Okada N; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Doddapaneni H; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Wang M; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Zhu Y; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Dinh H; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Okusaka T; Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Kokudo N; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kosuge T; Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Takayama T; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Fukayama M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Aburatani H; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Shibata T; 1] Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan. [2] Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2014 Dec; Vol. 46 (12), pp. 1267-73. Date of Electronic Publication: 2014 Nov 02.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genome, Human*
Mutation*
Carcinoma, Hepatocellular/*ethnology
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*ethnology
Liver Neoplasms/*genetics
Algorithms ; Asian People ; Carcinoma, Hepatocellular/epidemiology ; CpG Islands ; DNA Mutational Analysis ; Exome ; Gene Expression Regulation, Neoplastic ; Genome, Viral ; Hepacivirus/genetics ; Hepatitis B virus/genetics ; Humans ; Japan ; Liver Neoplasms/epidemiology ; Models, Statistical ; Principal Component Analysis ; TOR Serine-Threonine Kinases/genetics ; Telomerase/genetics ; United States ; White People